Searched for
INDIAN PHARMACEUTICAL ALLIANCE
Govt outlines next phase of pharma growthThe government highlighted its achievements, reforms, and policy initiatives, aiming to boost exports from $31 billion to $50 billion by 20...
Venezuela's acting President Delcy Rodríguez begins India visit as oil ties deepenVenezuela's acting President Delcy Eloina Rodriguez Gomez is in India for a five-day visit. She will meet Prime Minister Narendra Modi. The...
India and Ecuador exploring preferential trade deal to boost economic tiesIndia and Ecuador are strengthening ties. Discussions focused on a preferential trade agreement. Cooperation will expand in healthcare, agr...
Quant Mutual Fund sees ideal time to rebalance portfolios, remains heavily deployed on attractive valuationsQuant Mutual Fund advises aggressive portfolio rebalancing amid improving market conditions, citing attractive valuations and strong liquid...
Amazon signs $30 million deal to buy carbon credits from Indian rice farmersAmazon has signed a $30 million (around ₹280 crore) agreement with the Good Rice Alliance, backed by Bayer, Temasek’s GenZero and Shell, to...
Marketing practices framework: DoP panel to meet drug lobby groups"In the meeting as part of stakeholder consultations, the committee has desired to have the view of Organisation of Pharmaceutical Producer...
Govt should grant infrastructure status to API industry: IPA President Satish ReddyThe IPA wants the government to accord infrastructure status to the Active Pharmaceutical Ingredients (API) industry, and provide a boost t...
Shipment of hydroxychloroquine to US likely to start next week: IPA"The shipments of hydroxychloroquine to the US are likely to start next week. Indian pharma companies are committed to meet both, domestic ...
Industry players applaud govt's move to boost manufacturing of APIs, med devicesThe approved scheme will promote bulk drug parks for financing common infrastructure facilities in three bulk drug parks with a financial i...
Indian Pharmaceutical Alliance commits to help fight Covid-19The statement further said that the alliance is working closely with the International generic and biosimilar medicines association, the WH...
Expired, damaged drugs returned are not “supplies”; to save Rs 500 crore hitIndian Pharmaceutical Alliance had noted that the industry annually receives around Rs 3300 to Rs 5500 crore in expired or damaged stock an...
'Government plan may bring non-essential drugs under price control'Chemicals and Fertilisers ministry in a statement issued last week had said that the Department of Pharmaceuticals (DoP) is considering a c...
The full spectrum on FDI in brownfield companiesWe must first assess the need of the pharma sector and then evaluate whether mere change of ownership would meet its needs.
Indian Pharmaceutical Alliance slams US over charges on Indian patent lawIf a country feels that a provision or policy of another nation discriminates against its companies, it can challenge that under WTO's disp...
- Pharmaceutical industry agrees to enforcement of marketing code: Indian Pharmaceutical Alliance
Pharma industry has agreed in principle to enforce a code that will restrict them from offering gifts or other sops to doctors in order to ...
- Cost-based pricing to hit exports, says Indian Pharmaceutical Alliance
A Group of Ministers is finalising the National Pharmaceutical Pricing Policy (NPPP), which seeks to fix the prices of 348 essential drugs.
- Pharmaceuticals department may link drug prices with government procurement rates
DoP is considering linking mkt prices of medicines to rates at which govt procures generic drugs in bulk for its hospitals and health progr...
- National Pharmaceuticals Pricing Policy may cost pharma firms Rs 3,000 crore:Industry
"The IPA estimates that domestic price reductions alone will result in aggregate loss of sales of nearly Rs 3,000 crore, to the industry," ...
- Drug cos eye US entry after FDA checks
The US drug regulator has inspected the manufacturing plants of at least half-a-dozen Indian drugmakers, raising hopes that these companies...
- Indian drugmakers gear up to challenge frivolous MNC patents
Leading domestic drugmakers have decided to collectively challenge frivolous patent applications filed by multinationals in India under the...